Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the AT...

Saved in:

Bibliographic Details

Authors and Corporations:	Lux, Michael P., Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt, Schneeweiss, Andreas
Title:	Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
Type of Resource:	E-Article
Language:	English
published:	Basel Karger 2010 Online-Ausg.. 2014
Series:	, Onkologie 2010;33:155–166, ISSN: 0378-584X
Subjects:	Anastrozol Kosten-Effektivitäts-Analyse Kosten-Nutzwert-Analyse Icer Incremental Cost-Effectiveness Ratio Tamoxifen Qaly Anastrozole Cost-Effectiveness Analysis Cost-Utility Analysis
Source:	Qucosa